HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Dapoxetine for premature ejaculation: Advances in clinical studies].

Abstract
Premature ejaculation (PE) is a most common sexual dysfunction, for which dapoxetine, a novel selective serotonin (5-HT) re-uptake inhibitor (SSRI), is the only licensed oral medicine at present. With the advantages of fast absorption, rapid action, on-demand medication, and short half-life time, dapoxetine has been proved by clinical trials to be effective in prolonging the intravaginal ejaculation latency time (IELT) and improving the overall condition of PE patients in various areas and populations. Compared with the traditional SSRIs, dapoxetine has a better safety and tolerability. The most frequently reported dapoxetine-related adverse events include nausea, diarrhea, headache and dizziness, but with very few severe or serious cases.
AuthorsTing-you Zhou, Yan-feng Li
JournalZhonghua nan ke xue = National journal of andrology (Zhonghua Nan Ke Xue) Vol. 21 Issue 10 Pg. 931-6 (Oct 2015) ISSN: 1009-3591 [Print] China
PMID26665685 (Publication Type: Journal Article)
Chemical References
  • Benzylamines
  • Naphthalenes
  • Serotonin Uptake Inhibitors
  • dapoxetine
Topics
  • Benzylamines (therapeutic use)
  • Biomedical Research
  • Ejaculation (drug effects)
  • Humans
  • Male
  • Naphthalenes (therapeutic use)
  • Premature Ejaculation (drug therapy)
  • Reaction Time (drug effects)
  • Selective Serotonin Reuptake Inhibitors (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: